New data reveals that retatrutide, a dual-action medication, may represent a major advance in weight reduction . This drug combines the effects of a GLP-1 analog and a GIP receptor , potentially offering https://yoursocialpeople.com/story7119921/a-new-breakthrough-for-weight-control